{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:03:51Z","timestamp":1758042231468,"version":"3.44.0"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ajo.2020.07.054","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T22:50:47Z","timestamp":1603234247000},"page":"216-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Comment on: Long-term Results of Trimethoprim Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis"],"prefix":"10.1016","volume":"220","author":[{"given":"Devesh","family":"Kumawat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramanuj","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranita","family":"Sahay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2020.07.054_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ajo.2019.12.025","article-title":"Long-term results of trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrent Toxoplasma gondii retinochoroiditis","volume":"213","author":"Fernandes Felix","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2020.07.054_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7326\/0003-4819-91-3-420","article-title":"Trimethoprim-sulfamethoxazole in the United States","volume":"91","author":"Wormser","year":"1979","journal-title":"Ann Intern Med"},{"issue":"16","key":"10.1016\/j.ajo.2020.07.054_bib3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1503\/cmaj.111152","article-title":"Considerations when prescribing trimethoprim\u2013sulfamethoxazole","volume":"183","author":"Ho","year":"2011","journal-title":"CMAJ Can Med Assoc J"},{"issue":"1","key":"10.1016\/j.ajo.2020.07.054_bib4","first-page":"CD007417","article-title":"Corticosteroids as adjuvant therapy for ocular toxoplasmosis","volume":"1","author":"Jasper","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.ajo.2020.07.054_bib5","doi-asserted-by":"crossref","first-page":"e0004892","DOI":"10.1371\/journal.pntd.0004892","article-title":"The impact of short-term, intensive antifolate treatment (with pyrimethamine and sulfadoxine) and antibiotics followed by long-term, secondary antifolate prophylaxis on the rate of toxoplasmic retinochoroiditis recurrence","volume":"10","author":"Borkowski","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.ajo.2020.07.054_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9394(02)01527-1","article-title":"The effect of long-term intermittent trimethoprim\/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis","volume":"134","author":"Silveira","year":"2002","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942030427X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293942030427X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:44:31Z","timestamp":1757598271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293942030427X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":6,"alternative-id":["S000293942030427X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2020.07.054","relation":{},"ISSN":["0002-9394"],"issn-type":[{"type":"print","value":"0002-9394"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment on: Long-term Results of Trimethoprim Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2020.07.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2019.12.025","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}